000154187 001__ 154187
000154187 005__ 20240229120023.0
000154187 0247_ $$2doi$$a10.3390/jcm8122222
000154187 0247_ $$2pmid$$apmid:31888178
000154187 0247_ $$2pmc$$apmc:PMC6947510
000154187 037__ $$aDKFZ-2020-00644
000154187 041__ $$aeng
000154187 082__ $$a610
000154187 1001_ $$00000-0003-1447-9908$$aSchaller-Paule, Martin A$$b0
000154187 245__ $$aDelayed Occurrence of Hypertrophic Olivary Degeneration after Therapy of Posterior Fossa Tumors: A Single Institution Retrospective Analysis.
000154187 260__ $$aBasel$$bMDPI$$c2019
000154187 3367_ $$2DRIVER$$aarticle
000154187 3367_ $$2DataCite$$aOutput Types/Journal article
000154187 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1585216007_30735
000154187 3367_ $$2BibTeX$$aARTICLE
000154187 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154187 3367_ $$00$$2EndNote$$aJournal Article
000154187 520__ $$a(1) Background: A lesion within the dentato-rubro-olivary pathway (DROP) in the posterior fossa can cause secondary neurodegeneration of the inferior olivary nucleus: so-called hypertrophic olivary degeneration (HOD). The clinical syndrome of HOD occurs slowly over months and may be overlooked in progressive neuro-oncological diseases. Posterior fossa tumors are often located near these strategic structures. The goal of this study was to analyze the systematics of HOD occurrence in neuro-oncological patients. (2) Methods: The neuroradiological database of the university healthcare center was scanned for HOD-related terms from 2010 to 2019. After excluding patients with other causes of HOD, 12 datasets from neuro-oncological patients were analyzed under predetermined criteria. (3) Results: Patients received multimodal tumor treatments including neurosurgery, radiotherapy, and chemotherapy. HOD occurred both unilaterally (left n = 4; right n = 5) and bilaterally (n = 3). Though the mass effect of posterior fossa tumors had already affected strategic structures of the DROP, none of the patients showed signs of HOD on MRI until therapeutic measures including neurosurgery affecting the DROP were applied. HOD was visible on MRI within a median of 6 months after the neurosurgical intervention. In 67%, the presumed underlying surgical lesion in the DROP lay in the contralateral dentate nucleus. (4) Conclusion: In a selected cohort of neuro-oncological patients, therapeutic lesions within the DROP were associated with HOD occurrence.
000154187 536__ $$0G:(DE-HGF)POF3-899$$a899 - ohne Topic (POF3-899)$$cPOF3-899$$fPOF III$$x0
000154187 588__ $$aDataset connected to CrossRef, PubMed,
000154187 7001_ $$aFoerch, Christian$$b1
000154187 7001_ $$aKluge, Sara$$b2
000154187 7001_ $$00000-0002-2563-2691$$aBaumgarten, Peter$$b3
000154187 7001_ $$aKonczalla, Jürgen$$b4
000154187 7001_ $$0P:(DE-HGF)0$$aSteinbach, Joachim P$$b5
000154187 7001_ $$aWagner, Marlies$$b6
000154187 7001_ $$00000-0002-7209-3694$$aLuger, Anna-Luisa$$b7
000154187 773__ $$0PERI:(DE-600)2662592-1$$a10.3390/jcm8122222$$gVol. 8, no. 12, p. 2222 -$$n12$$p2222 $$tJournal of Clinical Medicine$$v8$$x2077-0383$$y2019
000154187 909CO $$ooai:inrepo02.dkfz.de:154187$$pVDB
000154187 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000154187 9101_ $$0I:(DE-588b)2036810-0$$60000-0002-7209-3694$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000154187 9131_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000154187 9141_ $$y2019
000154187 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN MED : 2017
000154187 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154187 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154187 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000154187 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000154187 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000154187 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000154187 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000154187 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000154187 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000154187 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154187 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154187 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154187 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ CLIN MED : 2017
000154187 9201_ $$0I:(DE-He78)L501-20160331$$kL501$$lDKTK Frankfurt$$x0
000154187 980__ $$ajournal
000154187 980__ $$aVDB
000154187 980__ $$aI:(DE-He78)L501-20160331
000154187 980__ $$aUNRESTRICTED